ASE Statement on Adapting Pediatric, Fetal, and Congenital Heart Disease Echocardiographic Services to the Evolving COVID-19 Pandemic - 03/05/21
Doi : 10.1016/j.echo.2021.01.012
Carolyn A. Altman, MD, FASE (Chair) a, ⁎ 
, Mary T. Donofrio, MD, FASE b, Bhawna Arya, MD, FASE c, Melissa Wasserman, RDCS, RCCS, FASE d, Gregory J. Ensing, MD, FASE e, Meryl S. Cohen, MD, MS Ed, FASE d, Mark B. Lewin, MD, FASE c, Madhav Swaminathan, MD, FASE f, Piers C.A. Barker, MD, FASE f
, Mary T. Donofrio, MD, FASE b, Bhawna Arya, MD, FASE c, Melissa Wasserman, RDCS, RCCS, FASE d, Gregory J. Ensing, MD, FASE e, Meryl S. Cohen, MD, MS Ed, FASE d, Mark B. Lewin, MD, FASE c, Madhav Swaminathan, MD, FASE f, Piers C.A. Barker, MD, FASE f a Division of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Houston, Texas
b Division of Pediatric Cardiology, Children's National Hospital, George Washington University School of Medicine, Washington, District of Columbia
c Division of Cardiology, Department of Pediatrics, University of Washington/Seattle Children's Hospital, Seattle, Washington
d University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
e University of Michigan/C.S. Mott Children's Hospital, Ann Arbor, Michigan
f Duke University, Durham, North Carolina
∗Reprint requests: Carolyn A. Altman, MD, FASE, Division of Pediatric Cardiology, Department of Pediatrics, , Baylor College of Medicine/Texas Children's Hospital, 6621 Fannin, MC 2-2280, Houston, TX 77030.Division of Pediatric CardiologyDepartment of Pediatrics, Baylor College of Medicine/Texas Children's Hospital6621 FanninMC 2-2280HoustonTX77030
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Over the 12 months since the start of the coronavirus disease 2019 pandemic, an explosion of investigation and an increase in experience have led to vast improvement in our knowledge about this disease. However, coronavirus disease 2019 remains a huge public health threat.
Le texte complet de cet article est disponible en PDF.Highlights |
• | This Statement offers updated information and guidance for providing echocardiography services in light of improved understanding of COVID-19 risks and course in our pediatric, congenital heart disease, and fetal cardiology patients. |
• | Referral for fetal echo may be gradually reintroduced to pre-pandemic norms, with the addition of telemedicine as an essential and valuable tool. |
• | MIS-C is frequently associated with cardiac abnormalities, with echo playing a vital role in assessment for abnormal ventricular function by ejection fraction and strain imaging, valvulitis, coronary artery dilation, intra-cardiac thrombus, or pericardial effusion. |
• | Essential trainee education in pediatric, congenital and fetal echo is feasible with stringent attention to PPE, incorporation of remote learning, thoughtful patient selection, and the use of scan protocols. |
• | Excellent communication, focused but thorough scan protocols, PPE, and flexible scheduling are essential for successful lab workflow and sonographer well-being. |
Keywords : COVID-19, Pediatric, Fetal, Congenital, Heart disease
Abbreviations : ASE, CDC, COVID-19, KD, MIS-C, MRI, PPE, SARS-CoV-2
Plan
| Endorsed by the Society of Pediatric Echocardiography and the Fetal Heart Society. © 2021 American Society of Echocardiography. |
|
| Conflicts of interest: None. |
|
| Notice and Disclaimer: This statement reflects recommendations based on expert opinion, national guidelines, and available evidence. Our knowledge with regard to COVID-19 continues to evolve, as do our institutional protocols for dealing with invasive and noninvasive procedures and practice of personal protective equipment. Readers are urged to follow national guidelines and their institutional recommendations regarding best practices to protect their patients and themselves. These reports are made available by the ASE as a courtesy reference source for its members. The reports contain recommendations only and should not be used as the sole basis to make medical practice decisions or for disciplinary action against any employee. The statements and recommendations contained in these reports are based primarily on the opinions of experts, rather than on scientifically verified data. The ASE makes no express or implied warranties regarding the completeness or accuracy of the information in these reports, including the warranty of merchantability or fitness for a particular purpose. In no event shall the ASE be liable to you, your patients, or any other third parties for any decision made or action taken by you or such other parties in reliance on this information. Nor does your use of this information constitute the offering of medical advice by ASE or create any physician-patient relationship between ASE and your patients or anyone else. |
© 2021
American Society of Echocardiography. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 34 - N° 5
P. 553-561 - mai 2021 Retour au numéro
Article précédent
- An Electronic Health Record Intervention to Increase Utilization of Limited Transthoracic Echocardiography
- Corey Rearick, Jason Castaneda, Joseph Weber, Eve Edstrom, Kimisha Cassidy, Vineet Arora, R. Parker Ward
- Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study
- William E. Moody, Boyang Liu, Hani M. Mahmoud-Elsayed, Jonathan Senior, Sasha S. Lalla, Ayisha M. Khan-Kheil, Stewart Brown, Abdullah Saif, Alastair Moss, William M. Bradlow, Jeffrey Khoo, Mubarak Ahamed, Christopher McAloon, Sandeep S. Hothi, Richard P. Steeds
Bienvenue sur EM-consulte, la référence des professionnels de santé.